within Pharmacolibrary.Drugs.ATC.A;

model A03AB06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.03,
    Cl             = 0.3333333333333333,
    adminDuration  = 600,
    adminMass      = 0.04,
    adminCount     = 1,
    Vd             = 0.03,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Otilonium bromide is a synthetic quaternary ammonium compound with spasmolytic and antimuscarinic properties. It is used primarily for the treatment of irritable bowel syndrome (IBS) and related gastrointestinal disorders, particularly for the relief of abdominal pain and intestinal cramping. It is approved and in use in several countries for these indications.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult humans, as clinical studies have shown extremely low systemic absorption and rapid GI elimination. No quantitative clinical PK model is published.</p><h4>References</h4><ol><li><p>Shin, BS, et al., &amp; Yoo, SD (2008). Oral bioavailability and enterohepatic recirculation of otilonium bromide in rats. <i>Archives of pharmacal research</i> 31(1) 117–124. DOI:<a href=&quot;https://doi.org/10.1007/s12272-008-1129-2&quot;>10.1007/s12272-008-1129-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18277617/&quot;>https://pubmed.ncbi.nlm.nih.gov/18277617</a></p></li><li><p>Evangelista, S, et al., &amp; Maggi, CA (2000). A distribution study with (14)C-otilonium bromide in the rat: evidence for selective tropism for large intestine after oral administration. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 28(6) 643–647. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10820135/&quot;>https://pubmed.ncbi.nlm.nih.gov/10820135</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A03AB06;
